{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:23:30Z","timestamp":1794486210646,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112568","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:18:16Z","timestamp":1746184696000},"page":"112568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Yan","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minsi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112568_bib1","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.112568_bib2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/ecco-jcc\/jjx103","article-title":"Endoscopic and Histological Mucosal Healing in Ulcerative Colitis in the First Year of Diagnosis: Results from a Population-based Inception Cohort from Six Countries in Asia","volume":"11","author":"Leung","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.isci.2025.112568_bib3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ibd.22939","article-title":"High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials","volume":"18","author":"R\u00f6mkens","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2025.112568_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2036.2007.03471.x","article-title":"Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates","volume":"26","author":"Safdi","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.112568_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.112568_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00018-022-04471-3","article-title":"5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism","volume":"79","author":"Huang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.112568_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","article-title":"Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease","volume":"29","author":"Mehta","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.112568_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-332205","article-title":"Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease","volume":"73","author":"Karmi","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.isci.2025.112568_bib9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.chom.2021.06.019","article-title":"Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease","volume":"29","author":"Lee","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2025.112568_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127660","article-title":"Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review","volume":"282","author":"Wang","year":"2024","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.isci.2025.112568_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.16656","article-title":"Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease","volume":"55","author":"Radhakrishnan","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.112568_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15227","article-title":"Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis","volume":"49","author":"Olaisen","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.112568_bib13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ng.3663","article-title":"The effect of host genetics on the gut microbiome","volume":"48","author":"Bonder","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.112568_bib14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/ecco-jcc\/jjz077","article-title":"Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations","volume":"13","author":"Klaassen","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.isci.2025.112568_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/nu14245233","article-title":"Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation","volume":"14","author":"Feng","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2025.112568_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep18507","article-title":"Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses","volume":"6","author":"Rossi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112568_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12866-015-0400-1","article-title":"Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model","volume":"15","author":"Mart\u00edn","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.isci.2025.112568_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease","volume":"65","author":"Qu\u00e9vrain","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.isci.2025.112568_bib19","doi-asserted-by":"crossref","first-page":"e00300-15","DOI":"10.1128\/mBio.00300-15","article-title":"Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii","volume":"6","author":"Miquel","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.112568_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00781-23","article-title":"Short-chain fatty acids of various lengths differentially inhibit Klebsiella pneumoniae and Enterobacteriaceae species","volume":"9","author":"Chang","year":"2024","journal-title":"mSphere"},{"key":"10.1016\/j.isci.2025.112568_bib21","first-page":"447","article-title":"Risk factors and management strategies associated with non-response to aminosalicylates as a maintenance treatment in ulcerative colitis","volume":"113","author":"Mart\u00ed-Aguado","year":"2021","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.isci.2025.112568_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2021.12.284","article-title":"Design of Clinical Trials for Mild to Moderate Ulcerative Colitis","volume":"162","author":"Sedano","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2025.112568_bib23","doi-asserted-by":"crossref","first-page":"e00188-17","DOI":"10.1128\/msystems.00188-17","article-title":"Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction","volume":"3","author":"Zhou","year":"2018","journal-title":"mSystems"},{"key":"10.1016\/j.isci.2025.112568_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2025.112568_bib25","doi-asserted-by":"crossref","first-page":"e02120-17","DOI":"10.1128\/mBio.02120-17","article-title":"Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients","volume":"9","author":"Doherty","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.112568_bib26","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.112568_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.112568_bib28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","article-title":"Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4","volume":"41","author":"Blanco-M\u00edguez","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.112568_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3","volume":"10","author":"Beghini","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.isci.2025.112568_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009442","article-title":"Multivariable association discovery in population-scale meta-omics studies","volume":"17","author":"Mallick","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2025.112568_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002687","article-title":"Inferring correlation networks from genomic survey data","volume":"8","author":"Friedman","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2025.112568_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"170","author":"Lennard-Jones","year":"1989","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.isci.2025.112568_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.mcna.2009.02.007","article-title":"Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults","volume":"93","author":"Krousel-Wood","year":"2009","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.isci.2025.112568_bib34","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","article-title":"Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms","volume":"13","author":"Wallen","year":"2022","journal-title":"Nat. Commun."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:02:25Z","timestamp":1768964545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225008296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225008296"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112568","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112568"}}